GRIGGIO, VALENTINA
GRIGGIO, VALENTINA
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells
2019-01-01 Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells
2011-01-01 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma
2015-01-01 Castella, B; Foglietta, M; Sciancalepore, P; Rigoni, M; Coscia, M; Griggio, V; Vitale, C; Ferracini, R; Saraci, E; Omedé, P; Riganti, C; Palumbo, A; Boccadoro, M; Massaia, M.
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia
2023-01-01 Vitale, Candida; Griggio, Valentina; Todaro, Maria; Riganti, Chiara; Jones, Rebecca; Boccellato, Elia; Perutelli, Francesca; Arruga, Francesca; Vaisitti, Tiziana; Efremov, Dimitar G; Deaglio, Silvia; Landesman, Yosef; Bruno, Benedetto; Coscia, Marta
Autoimmune complications in chronic lymphocytic leukemia in the era of targeted drugs
2020-01-01 Vitale C.; Montalbano M.C.; Salvetti C.; Boccellato E.; Griggio V.; Boccadoro M.; Coscia M.
CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep?
2023-01-01 Vitale, Candida; Griggio, Valentina; Perutelli, Francesca; Coscia, Marta
Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights
2022-01-01 Salvetti, Chiara; Vitale, Candida; Griggio, Valentina; Drandi, Daniela; Jones, Rebecca; Bonello, Lisa; Bomben, Riccardo; Bragoni, Alberto; Bagnara, Davide; Fais, Franco; Gattei, Valter; Cavallo, Federica; Zamò, Alberto; Coscia, Marta
Cd200 baseline serum levels predict prognosis of chronic lymphocytic leukemia
2021-01-01 D'arena G.; Vitale C.; Coscia M.; Lamorte D.; Pietrantuono G.; Perutelli F.; D'auria F.; Statuto T.; Valvano L.; Tomasso A.; Griggio V.; Jones R.; Mansueto G.; Villani O.; D'agostino S.; Viglioglia V.; De Feo V.; Calapai F.; Mannucci C.; Sgambato A.; Efremov D.G.; Laurenti L.
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino
2019-01-01 Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.
2012-01-01 Coscia M; Vitale C; Peola S; Foglietta M; Rigoni M; Griggio V; Castella B; Angelini D; Chiaretti S; Riganti C; Guarini A; Drandi D; Ladetto M; Bosia A; Foà R; Battistini L; Boccadoro M; Fournié JJ; Massaia M.
Evaluation of the cytotoxic effect of selinexor in combination with chemotherapy or idelalisib towards primary CLL cells
2020-01-01 Vitale C, Todaro M, Griggio V, Salvetti C, Riganti C, Landesman Y, Boccadoro M, Coscia M.
HIF-1 alpha Upregulation in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role As a Therapeutic Target
2016-01-01 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Ruggeri, M; Omede, P; Laurenti, L; Del Poeta, G; Mauro, Fr; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia
2020-01-01 Griggio, Valentina; Vitale, Candida; Todaro, Maria; Riganti, Chiara; Kopecka, Joanna; Salvetti, Chiara; Bomben, Riccardo; Dal Bo, Michele; Magliulo, Daniela; Rossi, Davide; Pozzato, Gabriele; Bonello, Lisa; Marchetti, Monia; Omedè, Paola; Kodipad, Ahad Ahmed; Laurenti, Luca; Del Poeta, Giovanni; Mauro, Francesca Romana; Bernardi, Rosa; Zenz, Thorsten; Gattei, Valter; Gaidano, Gianluca; Foà, Robin; Massaia, Massimo; Boccadoro, Mario; Coscia, Marta
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia
2016-01-01 Griggio, Valentina; Mandili, Giorgia; Vitale, Candida; Capello, Michela; Macor, Paolo; Serra, Sara; Castella, Barbara; Peola, Silvia; Foglietta, Myriam; Drandi, Daniela; Omedé, Paola; Sblattero, Daniele; Cappello, Paola; Chiarle, Roberto; Deaglio, Silvia; Boccadoro, Mario; Novelli, Francesco; Massaia, Massimo; Coscia, Marta
Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia
2018-01-01 Griggio V, Vitale C, Todaro M, Mauro FR, Salvetti C, Pietrasanta D, Vincelli ID, Scarfo L, Del Poeta G, Gaidano G, Gattei V, Foà R, Boccadoro M, Coscia M
Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia
2019-01-01 Griggio V, Vitale C, Salvetti C, Mauro FR, Pietrasanta D, Vincelli ID, Scarfo L, Del Poeta G, Gaidano G, Gattei V, Foà R, Boccadoro M, Coscia M
IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF ANTIBODY IMMUNE RESPONSES ELICITED BY SELF ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2014-01-01 Griggio V; Mandili G; Vitale C; Capello M; Robino M; Rigoni M; Foglietta M; Castella B; Sciancalepore P; Macor P; Novelli F; Boccadoro M; Massaia M; Coscia M.
Identification and functional characterization of tumor specific antibody responses in chronic lymphocytic leukemia
2014-01-01 Griggio V; Mandili G; Vitale C; Capello M; Robino M; Rigoni M; Foglietta M; Castella B; Sciancalepore P; Canepari ME; Novelli F; Boccadoro M; Massaia M; Coscia M
Identification by serological proteome analysis (SERPA) of novel tumor associated antigens in chronic lymphocytic leukemia (CLL)
2011-01-01 M Coscia; V Griggio; M Capello; C Vitale; F Linty; S Peola; P Cappello; B Castella; M Rigoni; P Sciancalepore; D Drandi; M Ruggeri; P Omedè; M Ladetto; F Novelli; M Boccadoro; M Massaia
IDENTIFICATION BY SEROLOGICAL PROTEOME ANALYSIS (SERPA) OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
2010-01-01 Marta Coscia; Michela Capello; Valentina Griggio; Federica Linty; Candida Vitale; Silvia Peola; Barbara Castella; Micol Rigoni; Daniela Drandi; Marina Ruggeri; Paola Omedè; Marco Ladetto; Franco Novelli; Mario Boccadoro; Massimo Massaia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells | 2019 | Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta | |
| Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia | |
| Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma | 2015 | Castella, B; Foglietta, M; Sciancalepore, P; Rigoni, M; Coscia, M; Griggio, V; Vitale, C; Ferracini, R; Saraci, E; Omedé, P; Riganti, C; Palumbo, A; Boccadoro, M; Massaia, M. | |
| Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia | 2023 | Vitale, Candida; Griggio, Valentina; Todaro, Maria; Riganti, Chiara; Jones, Rebecca; Boccellato, Elia; Perutelli, Francesca; Arruga, Francesca; Vaisitti, Tiziana; Efremov, Dimitar G; Deaglio, Silvia; Landesman, Yosef; Bruno, Benedetto; Coscia, Marta | |
| Autoimmune complications in chronic lymphocytic leukemia in the era of targeted drugs | 2020 | Vitale C.; Montalbano M.C.; Salvetti C.; Boccellato E.; Griggio V.; Boccadoro M.; Coscia M. | |
| CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep? | 2023 | Vitale, Candida; Griggio, Valentina; Perutelli, Francesca; Coscia, Marta | |
| Case Report: Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights | 2022 | Salvetti, Chiara; Vitale, Candida; Griggio, Valentina; Drandi, Daniela; Jones, Rebecca; Bonello, Lisa; Bomben, Riccardo; Bragoni, Alberto; Bagnara, Davide; Fais, Franco; Gattei, Valter; Cavallo, Federica; Zamò, Alberto; Coscia, Marta | |
| Cd200 baseline serum levels predict prognosis of chronic lymphocytic leukemia | 2021 | D'arena G.; Vitale C.; Coscia M.; Lamorte D.; Pietrantuono G.; Perutelli F.; D'auria F.; Statuto T.; Valvano L.; Tomasso A.; Griggio V.; Jones R.; Mansueto G.; Villani O.; D'agostino S.; Viglioglia V.; De Feo V.; Calapai F.; Mannucci C.; Sgambato A.; Efremov D.G.; Laurenti L. | |
| Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino | 2019 | Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro | |
| Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells. | 2012 | Coscia M; Vitale C; Peola S; Foglietta M; Rigoni M; Griggio V; Castella B; Angelini D; Chiaretti S; Riganti C; Guarini A; Drandi D; Ladetto M; Bosia A; Foà R; Battistini L; Boccadoro M; Fournié JJ; Massaia M. | |
| Evaluation of the cytotoxic effect of selinexor in combination with chemotherapy or idelalisib towards primary CLL cells | 2020 | Vitale C, Todaro M, Griggio V, Salvetti C, Riganti C, Landesman Y, Boccadoro M, Coscia M. | |
| HIF-1 alpha Upregulation in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role As a Therapeutic Target | 2016 | Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Ruggeri, M; Omede, P; Laurenti, L; Del Poeta, G; Mauro, Fr; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M | |
| HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia | 2020 | Griggio, Valentina; Vitale, Candida; Todaro, Maria; Riganti, Chiara; Kopecka, Joanna; Salvetti, Chiara; Bomben, Riccardo; Dal Bo, Michele; Magliulo, Daniela; Rossi, Davide; Pozzato, Gabriele; Bonello, Lisa; Marchetti, Monia; Omedè, Paola; Kodipad, Ahad Ahmed; Laurenti, Luca; Del Poeta, Giovanni; Mauro, Francesca Romana; Bernardi, Rosa; Zenz, Thorsten; Gattei, Valter; Gaidano, Gianluca; Foà, Robin; Massaia, Massimo; Boccadoro, Mario; Coscia, Marta | |
| Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia | 2016 | Griggio, Valentina; Mandili, Giorgia; Vitale, Candida; Capello, Michela; Macor, Paolo; Serra, Sara; Castella, Barbara; Peola, Silvia; Foglietta, Myriam; Drandi, Daniela; Omedé, Paola; Sblattero, Daniele; Cappello, Paola; Chiarle, Roberto; Deaglio, Silvia; Boccadoro, Mario; Novelli, Francesco; Massaia, Massimo; Coscia, Marta | |
| Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia | 2018 | Griggio V, Vitale C, Todaro M, Mauro FR, Salvetti C, Pietrasanta D, Vincelli ID, Scarfo L, Del Poeta G, Gaidano G, Gattei V, Foà R, Boccadoro M, Coscia M | |
| Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia | 2019 | Griggio V, Vitale C, Salvetti C, Mauro FR, Pietrasanta D, Vincelli ID, Scarfo L, Del Poeta G, Gaidano G, Gattei V, Foà R, Boccadoro M, Coscia M | |
| IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF ANTIBODY IMMUNE RESPONSES ELICITED BY SELF ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2014 | Griggio V; Mandili G; Vitale C; Capello M; Robino M; Rigoni M; Foglietta M; Castella B; Sciancalepore P; Macor P; Novelli F; Boccadoro M; Massaia M; Coscia M. | |
| Identification and functional characterization of tumor specific antibody responses in chronic lymphocytic leukemia | 2014 | Griggio V; Mandili G; Vitale C; Capello M; Robino M; Rigoni M; Foglietta M; Castella B; Sciancalepore P; Canepari ME; Novelli F; Boccadoro M; Massaia M; Coscia M | |
| Identification by serological proteome analysis (SERPA) of novel tumor associated antigens in chronic lymphocytic leukemia (CLL) | 2011 | M Coscia; V Griggio; M Capello; C Vitale; F Linty; S Peola; P Cappello; B Castella; M Rigoni; P Sciancalepore; D Drandi; M Ruggeri; P Omedè; M Ladetto; F Novelli; M Boccadoro; M Massaia | |
| IDENTIFICATION BY SEROLOGICAL PROTEOME ANALYSIS (SERPA) OF TUMOR-ASSOCIATED ANTIGENS ELICITING ANTIBODY RESPONSES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) | 2010 | Marta Coscia; Michela Capello; Valentina Griggio; Federica Linty; Candida Vitale; Silvia Peola; Barbara Castella; Micol Rigoni; Daniela Drandi; Marina Ruggeri; Paola Omedè; Marco Ladetto; Franco Novelli; Mario Boccadoro; Massimo Massaia |